{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:59:14Z","timestamp":1772578754611,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009606","name":"Arabian Gulf University","doi-asserted-by":"publisher","award":["R05"],"award-info":[{"award-number":["R05"]}],"id":[{"id":"10.13039\/100009606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bone.2015.11.015","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T05:02:05Z","timestamp":1448427725000},"page":"187-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["FGF23\u2013S129F mutant bypasses ER\/Golgi to the circulation of hyperphosphatemic familial tumoral calcinosis patients"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5281-1783","authenticated-orcid":false,"given":"Said M.","family":"Shawar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad R.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassam R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferial M.","family":"Hudaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2015.11.015_bb0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3476(68)80315-4","article-title":"Tumoral calcinosis and pseudoxanthoma elasticum","volume":"72","author":"Najjar","year":"1968","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2015.11.015_bb0010","unstructured":"http:\/\/www.omim.org\/clinicalSynopsis\/211900"},{"key":"10.1016\/j.bone.2015.11.015_bb0015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/jid.2009.337","article-title":"Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification","volume":"130","author":"Sprecher","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bone.2015.11.015_bb0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2015.11.015_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2015.11.015_bb0030","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2015.11.015_bb0035","doi-asserted-by":"crossref","first-page":"E929","DOI":"10.1152\/ajpendo.90456.2008","article-title":"Molecular Genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis","volume":"295","author":"Garringer","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2015.11.015_bb0040","doi-asserted-by":"crossref","first-page":"496514","DOI":"10.1186\/1687-9856-2009-496514","article-title":"Fibroblast growth factor 23 (FGF23) and disorders of phosphate metabolism","volume":"2009","author":"Saito","year":"2009","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"10.1016\/j.bone.2015.11.015_bb0045","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis","volume":"90","author":"Larsson","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2015.11.015_bb0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23\u2013FGFR\u2013Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A.;"},{"key":"10.1016\/j.bone.2015.11.015_bb0055","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00232.2013","article-title":"Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4","volume":"306","author":"Gattineni","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bone.2015.11.015_bb0060","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2015.11.015_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.gene.2014.03.052","article-title":"A new missense mutation in FGF23 gene in a male with hyperostosis\u2013hyperphosphatemia syndrome (HHS)","volume":"542","author":"Abbasi","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.bone.2015.11.015_bb0070","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajmg.a.33337","article-title":"Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations","volume":"152A","author":"Ichikawa","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2015.11.015_bb0075","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2009-0961","article-title":"Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis","volume":"94","author":"Bergwitz","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2015.11.015_bb0080","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2015.11.015_bb0085","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cell.2011.07.021","article-title":"Rescue of DeltaF508-CFTR trafficking via a GRASP-dependent unconventional secretion pathway","volume":"146","author":"Gee","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bone.2015.11.015_bb0090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2011.10.045","article-title":"The Arabic allele: a single base pair substitution activates a 10-base downstream cryptic splice acceptor site in exon 12 of LDLR and severely decreases LDLR expression in two unrelated Arab families with familial hypercholesterolemia","volume":"220","author":"Shawar","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bone.2015.11.015_bb0095","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1073\/pnas.96.5.1936","article-title":"Inhibitory sites in enzymes: zinc removal and reactivation by thionein","volume":"96","author":"Maret","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2015.11.015_bb0100","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2005-0301","article-title":"A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis","volume":"90","author":"Araya","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2015.11.015_bb0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1152\/physrev.00027.2011","article-title":"The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology","volume":"92","author":"Guerriero","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bone.2015.11.015_bb0110","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/hmg\/ddi259","article-title":"ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome","volume":"14","author":"Chen","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2015.11.015_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Pages","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.11.015_bb0120","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2015.11.015_bb0125","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","article-title":"Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23","volume":"23","author":"Yamazaki","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2015.11.015_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0095","article-title":"The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis","volume":"194","author":"Razzaque","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bone.2015.11.015_bb0135","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/1947601910383011","article-title":"The unfolded protein response, degradation from endoplasmic reticulum and cancer","volume":"1","author":"Tsai","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bone.2015.11.015_bb0140","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1152\/ajpendo.00592.2009","article-title":"In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes","volume":"298","author":"Rajan","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2015.11.015_bb9100","doi-asserted-by":"crossref","first-page":"31010","DOI":"10.1074\/jbc.M113.510065","article-title":"Endoplasmic reticulum oxidoreductin-1alpha (Ero1alpha) improves folding and secretion of mutant proinsulin and limits mutant proinsulin-induced endoplasmic reticulum stress.","volume":"288","author":"Wright","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2015.11.015_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/jbmr.061105","article-title":"Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23","volume":"22","author":"Frishberg","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2015.11.015_bb0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1681\/ASN.2006020158","article-title":"Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy","volume":"18","author":"Jennings","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2015.11.015_bb0155","doi-asserted-by":"crossref","first-page":"F839","DOI":"10.1152\/ajprenal.00616.2012","article-title":"Renalase regulates renal dopamine and phosphate metabolism","volume":"305","author":"Sizova","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bone.2015.11.015_bb0160","doi-asserted-by":"crossref","first-page":"F355","DOI":"10.1152\/ajprenal.90426.2008","article-title":"Signaling pathways utilized by PTH and dopamine to inhibit phosphate transport in mouse renal proximal tubule cells","volume":"296","author":"Cunningham","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bone.2015.11.015_bb0165","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/pmic.200500535","article-title":"Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum\/plasma proteome profiling","volume":"6","author":"Hsieh","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.bone.2015.11.015_bb0175","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/jcp.2004.022186","article-title":"Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice","volume":"58","author":"Twomey","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bone.2015.11.015_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","article-title":"Regulation and function of the FGF23\/Klotho endocrine pathways","volume":"92","author":"Martin","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bone.2015.11.015_bb0185","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2015.11.015_bb0190","series-title":"Regulation of Phosphate Metabolism by FGF23","first-page":"137","author":"Lanske","year":"2013"},{"key":"10.1016\/j.bone.2015.11.015_bb0195","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/jcb.22842","article-title":"Both FGF23 and extracellular phosphate activate Raf\/MEK\/ERK pathway via FGF receptors in HEK293 cells","volume":"111","author":"Yamazaki","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2015.11.015_bb0200","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/0003-4819-77-5-741","article-title":"Treatment of tumoral calcinosis with phosphorus deprivation","volume":"77","author":"Mozaffarian","year":"1972","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2015.11.015_bb0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000197876","article-title":"Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer","volume":"71","author":"Lammoglia","year":"2009","journal-title":"Horm. Res."},{"key":"10.1016\/j.bone.2015.11.015_bb0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11914-015-0254-3","article-title":"Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action","volume":"13","author":"Folsom","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2015.11.015_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10937400701597766","article-title":"Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide","volume":"10","author":"Krewski","year":"2007","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.bone.2015.11.015_bb0225","first-page":"108","article-title":"Pancreatic enzyme replacement therapy for people with cystic fibrosis (review)","volume":"16","author":"Somaraju","year":"2015","journal-title":"Paediatr. Respir. Rev."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215004160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215004160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T03:38:45Z","timestamp":1565408325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328215004160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":44,"alternative-id":["S8756328215004160"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2015.11.015","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF23\u2013S129F mutant bypasses ER\/Golgi to the circulation of hyperphosphatemic familial tumoral calcinosis patients","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2015.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}